News & Articles

Which new products made the most difference to your lab work this year?

The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance

Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies

The collaboration will focus on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy

Watch world-renowned experts and connect with leading innovators on the hottest topics, new developments and latest technologies in neuroscience

Join us Thursday, November 5, to learn how to introduce base editing technology into your cell therapy pipeline

The Phase II clinical trial, which will use cutting-edge CRISPR genetic engineering, has already begun enrolling patients

Join us Tuesday, October 13, to hear from the multiplexing experts behind our four-part digital pathology webinar series

The Royal Swedish Academy of Sciences awards Nobel Prize in Chemistry 2020 to Emmanuelle Charpentier and Jennifer A. Doudna for the development of a method for genome editing

Explore our roundup of key considerations for a successful CRISPR/Cas9 experiment

The study has uncovered a genetic vulnerability present in nearly 10% percent of all breast cancers tumors

Watch this on-demand webinar to learn about the latest approaches in single nucleus transcriptomics and ATAC-Seq

Meet the researchers making waves in science and learn about the technologies innovating their research

Connecting the scientific community with two new online content-packed events

The new reagent kits aim to make whole genome sequencing more accessible and affordable for labs of all sizes

Just leave a quick lab product review today for your chance to scoop one of our weekly $100 prizes

Saphyr’s extremely sensitive structural variation detection technology will be used to analyze samples from COVID patients from dozens of clinical sites throughout North America and Europe

The FluidFM BOT BIO Series combines Olympus’ renowned optics with Cytosurge’s cell manipulation expertise

Paper published in npj Genomic Medicine demonstrates identification of more reportable CNVs with CytoSure v3 vs traditional array design

Whole-genome sequencing offers the ability to reduce pediatric diagnostic odysseys which cost at least $14 billion annually in the U.S.